AU Patent

AU2011343822B2 — Neuropeptide analogs, compositions, and methods for treating pain

Assigned to Neuroadjuvants Inc · Expires 2017-06-29 · 9y expired

What this patent protects

Neuropeptide analogs and compositions including neuropeptide analogs are described herein. Also provided are methods of producing and using the neuropeptide analogs and compositions including one or more neuropeptide analogs.

USPTO Abstract

Neuropeptide analogs and compositions including neuropeptide analogs are described herein. Also provided are methods of producing and using the neuropeptide analogs and compositions including one or more neuropeptide analogs.

Drugs covered by this patent

Patent Metadata

Patent number
AU2011343822B2
Jurisdiction
AU
Classification
—
Expires
2017-06-29
Drug substance claim
No
Drug product claim
No
Assignee
Neuroadjuvants Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.